NYSE: PAIIPyrophyte Acquisition Corp II Stock
$10.29+0.00 (+0%)
Updated Sep 18, 2026
PAII Price
$10.29
Fair Value Price
N/A
Market Cap
$280.58M
52 Week Low
$9.93
52 Week High
$10.31
P/E
38.11x
P/B
-30.05x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$6.04M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.04
Operating Cash Flow
-$1M
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PAII's potential to beat the market
- PAII doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
PAII
RankedUnranked of 29
RankedUnranked of 29
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.88 | C | |
| $10.90 | C | |
| $14.65 | C |
Be the first to know about important PAII news, forecast changes, insider trades & much more!
PAII News
Overview
Due Diligence Score
–
Industry Average (8)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PAII scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PAII is good value based on its earnings relative to its share price (38.11x), compared to the US market average (44.48x)
P/E vs Market Valuation
PAII is poor value based on its earnings relative to its share price (38.11x), compared to the US Shell Companies industry average (15.67x)
P/E vs Industry Valuation
PAII's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more PAII due diligence checks available for Premium users.
Valuation
PAII price to earnings (PE)
For valuing profitable companies with steady earnings
Company
38.11x
Industry
15.67x
Market
44.48x
PAII is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PAII is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PAII price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-30.05x
Industry
116.12x
PAII's financial health
Profit margin
Revenue
$0.0
Net Income
$1.5M
Profit Margin
0%
PAII's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$208.0M
Liabilities
$9.7M
Debt to equity
-1.04
PAII's short-term assets ($402.09k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PAII's long-term liabilities ($9.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PAII's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PAII's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$15.3k
Investing
$0.0
Financing
$0.0
PAII's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PAII vs Shell Company Stocks
Pyrophyte Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.